SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-157741
Filing Date
2021-05-11
Accepted
2021-05-11 17:10:28
Documents
4
Effectiveness Date
2021-05-11

Document Format Files

Seq Description Document Type Size
1 S-8 d904008ds8.htm S-8 48840
2 EX-5.1 d904008dex51.htm EX-5.1 6176
3 EX-23.1 d904008dex231.htm EX-23.1 1403
4 GRAPHIC g904008g44v19.jpg GRAPHIC 3796
  Complete submission text file 0001193125-21-157741.txt   62836
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256013 | Film No.: 21912387
SIC: 2836 Biological Products, (No Diagnostic Substances)